PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2026Journal of Clinical Medicine0 citationsOpen Access

Psychiatric and Neurological Involvement in COVID-19 Hospitalized Patients Through the Global Pandemic in Central Romania

View Full Paper
CLClaudia Daniela LupuLucian Blaga University of SibiuVCVlad-Dan CotuțiuVBVictoria BîrluțiuLucian Blaga University of Sibiu

Key Points

  • This research aims to investigate changes in neuropsychiatric manifestations among hospitalized COVID-19 patients across pandemic waves.
  • Conducted a retrospective observational study of 1471 hospitalized adults with confirmed SARS-CoV-2 infection.
  • Analyzed temporal trends of symptoms using a custom natural language processing pipeline.
  • Defined nine hierarchical clinical clusters for neuropsychiatric manifestations.
  • Applied multivariable logistic regression to assess trends and associations.
  • Performed age-stratified replication to validate findings.
  • Severe neurological presentations increased six-fold from 3.5% in Wave 1 to 20.1% in Wave 5.
  • Psychiatric symptoms declined significantly from 13.3% to 4.3%.
  • The overall neuropsychiatric burden remained stable around 40-45% despite the compositional shift.
  • The neurological trend persisted, showing an adjusted odds ratio of 4.34 for Wave 5 versus Wave 1.
  • The composite neurological severity index was a predictor of mortality and ICU admission.

Abstract

Background: Neuropsychiatric manifestations are a recognized complication of COVID-19, yet their temporal evolution across pandemic waves remains poorly characterized in hospitalized cohorts. This study examined whether their prevalence and composition changed across five successive waves. Methods: We conducted a retrospective observational study of 1471 hospitalized adults with confirmed Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at Sibiu County Emergency Clinical Hospital, Romania (March 2020–January 2025), spanning ancestral through Omicron variants. A custom natural language processing pipeline extracted symptoms, medications, and International Classification of Diseases, 10th Revision (ICD-10) codes from electronic medical records. Nine hierarchical clinical clusters were defined; temporal trends were assessed using multivariable logistic regression with age-stratified replication. Results: Severe neurological presentations (stroke, seizures, hemiparesis) increased six-fold from 3.5% in Wave 1 to 20.1% in Wave 5, while psychiatric symptoms (anxiety, insomnia) declined from 13.3% to 4.3%. Overall, neuropsychiatric burden remained stable (~40–45%), revealing a compositional shift. This neurological trend persisted after multivariable adjustment (adjusted odds ratio 4.34, for Wave 5 vs. Wave 1) and within age-stratified subgroups, was inversely associated with respiratory severity and could not be attributed to vaccination status. The composite neurological severity index independently predicted mortality and intensive care unit admission. Conclusions: Neuropsychiatric manifestations in hospitalized Coronavirus disease of 2019 (COVID-19) patients underwent a compositional shift from psychiatric dominance in early waves to severe neurological dominance in later waves, consistent with a transition from reactive psychiatric presentations toward progressive neurological injury. This pattern, largely independent of measured confounders, underscores the need for sustained neurological surveillance beyond the acute respiratory phase.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lupu et al. (2026) studied this question.

synapsesocial.com/papers/69e3211640886becb654053bhttps://doi.org/10.3390/jcm15083030
Ask AI
Helpful
Bookmark
Share
View Full Paper